- Home
- AMCX vs SGHT Comparison
AMCX vs SGHT Comparison
Compare AMCX & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMCX
- SGHT
- Stock Information
- Founded
- AMCX 1980
- SGHT 2011
- Country
- AMCX United States
- SGHT United States
- Employees
- AMCX N/A
- SGHT N/A
- Industry
- AMCX Cable & Other Pay Television Services
- SGHT Medical Specialities
- Sector
- AMCX Telecommunications
- SGHT Health Care
- Exchange
- AMCX Nasdaq
- SGHT Nasdaq
- Market Cap
- AMCX 292.9M
- SGHT 217.7M
- IPO Year
- AMCX 2011
- SGHT 2021
- Fundamental
- Price
- AMCX $6.29
- SGHT $4.22
- Analyst Decision
- AMCX Sell
- SGHT Buy
- Analyst Count
- AMCX 5
- SGHT 8
- Target Price
- AMCX $6.50
- SGHT $4.01
- AVG Volume (30 Days)
- AMCX 569.3K
- SGHT 176.9K
- Earning Date
- AMCX 08-08-2025
- SGHT 07-31-2025
- Dividend Yield
- AMCX N/A
- SGHT N/A
- EPS Growth
- AMCX N/A
- SGHT N/A
- EPS
- AMCX N/A
- SGHT N/A
- Revenue
- AMCX $2,380,086,000.00
- SGHT $78,109,000.00
- Revenue This Year
- AMCX N/A
- SGHT N/A
- Revenue Next Year
- AMCX N/A
- SGHT $11.60
- P/E Ratio
- AMCX N/A
- SGHT N/A
- Revenue Growth
- AMCX N/A
- SGHT N/A
- 52 Week Low
- AMCX $5.41
- SGHT $2.03
- 52 Week High
- AMCX $11.57
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- AMCX 49.10
- SGHT 61.79
- Support Level
- AMCX $5.90
- SGHT $4.02
- Resistance Level
- AMCX $6.38
- SGHT $4.46
- Average True Range (ATR)
- AMCX 0.34
- SGHT 0.22
- MACD
- AMCX -0.04
- SGHT -0.03
- Stochastic Oscillator
- AMCX 36.62
- SGHT 71.43
About AMCX AMC Networks Inc.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.